Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial.
Adv Ther
; 38(8): 4581-4591, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34241781
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Carcinoma, Squamous Cell
/
Antineoplastic Agents, Immunological
Limits:
Humans
Language:
En
Journal:
Adv Ther
Journal subject:
TERAPEUTICA
Year:
2021
Type:
Article
Affiliation country:
United States